脳脊髄液（CSF）管理機器の世界市場2017-2021...市場調査レポートについてご紹介

Table of Contents
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
• Key market highlights

PART 05: Overview: CSF management devices
• Background
• Regulatory environment

PART 06: Market landscape
• Market overview
• Five forces analysis

PART 07: Market segmentation by product
• CSF shunts
• CSF drainage systems

PART 08: Market segmentation by end-user
• Hospitals
• Ambulatory surgical centers (ASCs)

PART 09: Buying criteria

PART 10: Geographical segmentation
• CSF management devices market in Americas
• CSF management devices market in EMEA
• CSF management devices market in APAC

PART 11: Decision framework

PART 12: Drivers and challenges
• Market drivers
• Impact of drivers on key customer segments
• Market challenges
• Impact of challenges on key customer segments

PART 13: Market trends
• Growing technological advances
• Greater focus on emerging countries
• Attracting end-users through medical exhibitions

PART 14: Vendor landscape
• Competitive scenario

PART 15: Key vendor analysis
• B. Braun
• DePuy Synthes
• Integra LifeSciences
• Medtronic
• Sophysa
• Other prominent vendors

PART 16: Appendix
• List of abbreviations

[List of Exhibits]

Exhibit 01: Shunt malfunction symptoms
Exhibit 02: Classification of medical devices
Exhibit 03: Global CSF management devices market
Exhibit 04: Global CSF management devices market 2016-2021 ($ millions)
Exhibit 05: Global CSF management devices market analysis: Developed and emerging markets
Exhibit 06: Global CSF management devices market: Opportunity analysis
Exhibit 07: Five forces analysis
Exhibit 08: Global CSF management devices market by product type
Exhibit 09: Global CSF shunts market 2016-2021 ($ millions)
Exhibit 10: Global CSF drainage systems market 2016-2021 ($ millions)
Exhibit 11: Global CSF management devices market by product type 2016-2021
Exhibit 12: Global CSF management devices market analysis by product type 2016
Exhibit 13: Market growth lifecycle for global CSF management devices market 2016
Exhibit 14: Global CSF management devices market by product type 2016-2021 ($ millions)
Exhibit 15: Global CSF management devices market by product type 2016-2021 (%)
Exhibit 16: Global CSF management devices market by end-users in 2016
Exhibit 17: Key buying criteria for CSF management devices in global CSF management devices market
Exhibit 18: Global CSF management devices market by geography 2016-2021
Exhibit 19: Global CSF management devices market analysis by geography 2016
Exhibit 20: Geographical overview of global CSF management devices market 2016-2021
Exhibit 21: CSF management devices market in Americas 2016-2021 ($ millions)
Exhibit 22: Population over 65 years of age in EMEA countries 2015 (%)
Exhibit 23: CSF management devices market in EMEA 2016-2021 ($ millions)
Exhibit 24: CSF management devices market in APAC 2016-2021 ($ millions)
Exhibit 25: Global CSF management devices market by geography 2016-2021 ($ millions)
Exhibit 26: Global CSF management devices market by geography 2016-2021 (%)
Exhibit 27: Epidemiology of brain disorders in US 2014
Exhibit 28: Percentage of deaths from major neurological disorders
Exhibit 29: Brain and other nervous system cancer cases in US
Exhibit 30: Impact of drivers
Exhibit 31: Number of skilled physicians per 1,000 people (2014)
Exhibit 32: Impact of challenges
Exhibit 33: Country-wise healthcare spending list 2010-2016 estimated ($ billions)
Exhibit 34: Medical trade shows: Market impact on vendors
Exhibit 35: Competitive structure analysis of global CSF management devices market 2015
Exhibit 36: Competitive parameters in global CSF management devices market
Exhibit 37: Market penetration of various manufacturers of CSF management devices market 2016
Exhibit 38: Key highlights of B. Braun
Exhibit 39: B. Braun: Strength assessment
Exhibit 40: B. Braun: Strategy assessment
Exhibit 41: B. Braun: Opportunity assessment
Exhibit 42: Key highlights of DePuy Synthes
Exhibit 43: DePuy Synthes: Strength assessment
Exhibit 44: DePuy Synthes: Strategy assessment
Exhibit 45: DePuy Synthes: Opportunity assessment
Exhibit 46: Integra LifeSciences: Strength assessment
Exhibit 47: Integra LifeSciences: Strategy assessment
Exhibit 48: Integra LifeSciences: Opportunity assessment
Exhibit 49: Key highlights of Medtronic
Exhibit 50: Medtronic: Strength assessment
Exhibit 51: Medtronic: Strategy assessment
Exhibit 52: Medtronic: Opportunity assessment
Exhibit 53: Sophysa: Key highlights
Exhibit 54: Sophysa: Strength assessment
Exhibit 55: Sophysa: Strategy assessment
Exhibit 56: Sophysa: Opportunity assessment